Prajapati, S.; Hinchliffe, T.; Roy, V.; Shah, N.; Jones, C.N.; Obaid, G.
Biomimetic Nanotechnology: A Natural Path Forward for Tumor-Selective and Tumor-Specific NIR Activable Photonanomedicines. Pharmaceutics 2021, 13, 786.
https://doi.org/10.3390/pharmaceutics13060786
AMA Style
Prajapati S, Hinchliffe T, Roy V, Shah N, Jones CN, Obaid G.
Biomimetic Nanotechnology: A Natural Path Forward for Tumor-Selective and Tumor-Specific NIR Activable Photonanomedicines. Pharmaceutics. 2021; 13(6):786.
https://doi.org/10.3390/pharmaceutics13060786
Chicago/Turabian Style
Prajapati, Sushant, Taylor Hinchliffe, Vinay Roy, Nimit Shah, Caroline N. Jones, and Girgis Obaid.
2021. "Biomimetic Nanotechnology: A Natural Path Forward for Tumor-Selective and Tumor-Specific NIR Activable Photonanomedicines" Pharmaceutics 13, no. 6: 786.
https://doi.org/10.3390/pharmaceutics13060786
APA Style
Prajapati, S., Hinchliffe, T., Roy, V., Shah, N., Jones, C. N., & Obaid, G.
(2021). Biomimetic Nanotechnology: A Natural Path Forward for Tumor-Selective and Tumor-Specific NIR Activable Photonanomedicines. Pharmaceutics, 13(6), 786.
https://doi.org/10.3390/pharmaceutics13060786